Junfeng Zhu

558 total citations
31 papers, 393 citations indexed

About

Junfeng Zhu is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Junfeng Zhu has authored 31 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Complementary and alternative medicine. Recurrent topics in Junfeng Zhu's work include Traditional Chinese Medicine Analysis (6 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (3 papers). Junfeng Zhu is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (3 papers). Junfeng Zhu collaborates with scholars based in China and Hong Kong. Junfeng Zhu's co-authors include Yongjiang Wu, Shuqing Chen, Like Zhong, Jinghui Zhang, Ping Huang, Yiwen Zhang, Lianjun Luan, Yong Chen, Zongfu Pan and Yiping Ren and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Junfeng Zhu

29 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfeng Zhu China 11 193 90 73 47 47 31 393
Ke‐Ping Shen China 12 208 1.1× 85 0.9× 36 0.5× 68 1.4× 30 0.6× 21 417
Yuzhuo Wu China 13 231 1.2× 78 0.9× 75 1.0× 23 0.5× 117 2.5× 51 507
Ruolan Song China 17 336 1.7× 84 0.9× 80 1.1× 63 1.3× 68 1.4× 33 619
Xiaonan Chen China 13 232 1.2× 63 0.7× 67 0.9× 22 0.5× 72 1.5× 30 402
Wafaa S. Ramadan United Arab Emirates 14 346 1.8× 60 0.7× 41 0.6× 103 2.2× 47 1.0× 39 627
Jagadeesh Kumar Gangasani India 14 152 0.8× 48 0.5× 24 0.3× 39 0.8× 43 0.9× 33 435
Lintao Han China 13 237 1.2× 50 0.6× 71 1.0× 39 0.8× 69 1.5× 33 445
Ming-Jen Fan Taiwan 12 249 1.3× 120 1.3× 45 0.6× 41 0.9× 51 1.1× 14 494
Hangyu Wang China 16 277 1.4× 124 1.4× 62 0.8× 44 0.9× 82 1.7× 42 561

Countries citing papers authored by Junfeng Zhu

Since Specialization
Citations

This map shows the geographic impact of Junfeng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Zhu more than expected).

Fields of papers citing papers by Junfeng Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Zhu. The network helps show where Junfeng Zhu may publish in the future.

Co-authorship network of co-authors of Junfeng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Zhu. A scholar is included among the top collaborators of Junfeng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Zhu. Junfeng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Junfeng, et al.. (2025). Identification and validation of PANoptosis-related LncRNAs prognosis system in hepatocellular carcinoma. Scientific Reports. 15(1). 6030–6030. 2 indexed citations
2.
Chen, Siqi, Chenchen Jiang, Yan Feng, et al.. (2025). Validated target-based network pharmacology reveals that salvianolic acid C attenuates doxorubicin-induced cardiotoxicity by regulating apoptosis and oxidative stress. Biochemical and Biophysical Research Communications. 775. 152196–152196. 2 indexed citations
3.
Wang, Qi, et al.. (2024). Ferroptosis: A novel therapeutic target of natural products against doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy. 178. 117217–117217. 17 indexed citations
4.
6.
Ding, Haiying, Like Zhong, Junfeng Zhu, et al.. (2024). Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer. European Journal of Clinical Pharmacology. 80(9). 1399–1407.
8.
Zhong, Like, et al.. (2023). A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma. Journal of Oncology. 2023. 1–18. 5 indexed citations
9.
She, Han, et al.. (2023). Construction and validation of a mitochondria-associated genes prognostic signature and immune microenvironment characteristic of sepsis. International Immunopharmacology. 126. 111275–111275. 6 indexed citations
10.
Zhong, Like, et al.. (2023). Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer. Cancer Chemotherapy and Pharmacology. 92(3). 181–192. 3 indexed citations
11.
She, Han, et al.. (2023). Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis. Frontiers in Immunology. 14. 1184126–1184126. 25 indexed citations
13.
15.
Zhu, Junfeng, Jinghui Zhang, Yun Gao, et al.. (2018). Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC–MS based non-targeted metabolomic analysis. Journal of Pharmaceutical and Biomedical Analysis. 152. 264–270. 29 indexed citations
16.
Zhu, Junfeng, et al.. (2017). Rapid screening of brain-penetrable antioxidants from natural products by blood-brain barrier specific permeability assay combined with DPPH recognition. Journal of Pharmaceutical and Biomedical Analysis. 151. 42–48. 19 indexed citations
17.
Zhu, Junfeng, et al.. (2017). Chemical profiling and antioxidant evaluation of Yangxinshi Tablet by HPLC–ESI-Q-TOF-MS/MS combined with DPPH assay. Journal of Chromatography B. 1060. 262–271. 50 indexed citations
18.
Zhu, Junfeng, et al.. (2016). Drug-protein binding of Danhong injection and the potential influence of drug combination with aspirin: Insight by ultrafiltration LC–MS and molecular modeling. Journal of Pharmaceutical and Biomedical Analysis. 134. 100–107. 25 indexed citations
19.
Zhu, Junfeng, Zhengyu Jiang, Mengchen Lu, et al.. (2014). Insights into Targeting NEMO for Pharmacological Regulation. Current Drug Targets. 15(9). 874–887. 1 indexed citations
20.
Zhu, Junfeng, Zhihong Mo, Shun Feng, et al.. (2006). Development of an effective sample preparation approach for proteomic analysis of silkworm eggs using two-dimensional gel electrophoresis and mass spectrometry. Journal of Chromatography A. 1128(1-2). 133–137. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026